Facet Biotech Articles
M&A news: Tongjitang gets takeover offer from Hanmax; Abbott’s takeover of Facet cleared under US act
9 April 2010
Showing 1-2 of 2 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
